Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Abbvie Inc. (ABBV)  
$169.42 0.85 (0.5%) as of 4:30 Fri 6/7


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 1,770,000,000
Market Cap: 299.87(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $132.51 - $182.1
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  560
Guru Rank Value     : 3
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   AbbVie is a research-based biopharmaceutical company. Co. operates as a single business segment dedicated to the research and development, manufacturing, commercialization and sale of medicines and therapies. Co.'s products include: immunology products such as Humira, Skyrizi, and Rinvoq; oncology products such as Imbruvica and Venclexta/Venclyxto; aesthetics products such as Botox Cosmetic and Juvederm Collection; neuroscience products such as Botox Therapeutic, Vraylar, and Ubrelvy; eyecare products such as Lumigan/Ganfort, Alphagan/Combigan, and Restasis; women's health products such as Lo Loestrin and Orilissa/Oriahnn; and other key products such as Creon, Lupron, and Synthroid.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 80,031 461,916 540,416 831,596
Total Sell Value $14,256,265 $81,646,316 $93,320,391 $138,453,569
Total People Sold 2 9 9 12
Total Sell Transactions 2 11 13 29
End Date 2024-03-10 2023-12-08 2023-06-09 2022-06-09

   
Records found: 765
  Page 2 of 31  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Siatis Perry C EVP, GC AND SECRETARY   •       –      –    2024-02-28 4 D $178.99 $1,411,336 D/D (7,885) 20,288     -
   Saleki-Gerhardt Azita EVP, CHIEF OPERATIONS OFFICER   •       –      –    2024-02-28 4 D $178.99 $4,289,674 D/D (23,966) 219,978     -
   Thakkar Roopal SVP, CMO, GLOBAL THERAPEUTICS   •       –      –    2024-02-28 4 D $178.99 $879,557 D/D (4,914) 23,259     -
   Reents Scott T EVP, CHIEF FINANCIAL OFFICER   •       –      –    2024-02-28 4 D $178.99 $2,082,370 D/D (11,634) 15,431     -
   Donoghoe Nicholas EVP, CHIEF BUS/STRAT OFFICER   •       –      –    2024-02-28 4 D $178.99 $3,001,841 D/D (16,771) 76,985     -
   Michael Robert A. PRES & CHIEF OPERATING OFFICER   •       –      –    2024-02-28 4 D $178.99 $6,736,826 D/D (37,638) 145,964     -
   Gonzalez Richard A CHAIRMAN OF THE BOARD AND CEO   •       •      –    2024-02-28 4 S $177.27 $24,572,458 D/D (138,616) 519,099 5%     
   Gonzalez Richard A CHAIRMAN OF THE BOARD AND CEO   •       •      –    2024-02-28 4 D $178.99 $19,733,469 D/D (110,249) 657,715     -
   Gonzalez Richard A CHAIRMAN OF THE BOARD AND CEO   •       •      –    2024-02-27 4 GD $0.00 $0 D/D 4,195 767,964     -
   Reents Scott T EVP, CHIEF FINANCIAL OFFICER   •       –      –    2024-02-23 4 S $177.44 $2,509,002 D/D (14,140) 27,065 5%     
   Reents Scott T EVP, CHIEF FINANCIAL OFFICER   •       –      –    2024-02-23 4 OE $61.36 $867,630 D/D 14,140 41,205     -
   Siatis Perry C EVP, GC AND SECRETARY   •       –      –    2024-02-23 4 AS $177.51 $2,441,295 D/D (13,753) 28,173 -5%     
   Siatis Perry C EVP, GC AND SECRETARY   •       –      –    2024-02-23 4 OE $105.92 $1,889,115 D/D 13,753 41,926     -
   Saleki-Gerhardt Azita EVP, CHIEF OPERATIONS OFFICER   •       –      –    2024-02-21 4 S $173.71 $9,184,048 D/D (52,870) 243,944 4%     
   Saleki-Gerhardt Azita EVP, CHIEF OPERATIONS OFFICER   •       –      –    2024-02-21 4 OE $58.88 $3,112,986 D/D 52,870 296,814     -
   Buckbee Kevin K SVP, CONTROLLER   •       –      –    2024-02-15 4 A $0.00 $0 D/D 12,048 19,211     -
   Saleki-Gerhardt Azita EVP, CHIEF OPERATIONS OFFICER   •       –      –    2024-02-15 4 A $0.00 $0 D/D 54,095 243,944     -
   Michael Robert A. PRES & CHIEF OPERATING OFFICER   •       –      –    2024-02-15 4 A $0.00 $0 D/D 84,957 183,602     -
   Richmond Timothy J. EVP, CHIEF HR OFFICER   •       –      –    2024-02-15 4 A $0.00 $0 D/D 53,827 67,664     -
   Gonzalez Richard A CHAIRMAN OF THE BOARD AND CEO   •       •      –    2024-02-15 4 A $0.00 $0 D/D 248,865 772,159     -
   Siatis Perry C EVP, GC AND SECRETARY   •       –      –    2024-02-15 4 A $0.00 $0 D/D 17,796 28,173     -
   Stewart Jeffrey Ryan EVP, CHIEF COMMERCIAL OFFICER   •       –      –    2024-02-15 4 A $0.00 $0 D/D 58,960 119,901     -
   Donoghoe Nicholas EVP, CHIEF BUS/STRAT OFFICER   •       –      –    2024-02-15 4 A $0.00 $0 D/D 37,853 93,756     -
   Thakkar Roopal SVP, CMO, GLOBAL THERAPEUTICS   •       –      –    2024-02-15 4 A $0.00 $0 D/D 17,796 28,173     -
   Hudson Thomas J SVP, CSO, GLOBAL RESEARCH   •       –      –    2024-02-15 4 A $0.00 $0 D/D 46,572 127,901     -
  765 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 2 of 31
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us